trial

Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia

NCTId NCT05643196
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 15 (actual)
Sponsored by NYU Langone Health
Primary completion 2024-03-25
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
15 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2023-04-06
Primary completion
2024-03-25
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
PLIFUSMRI

Sponsors

NYU Langone HealthLead Sponsor
The New York Community TrustCollaborator
Doris Duke Charitable FoundationCollaborator

Investigators

1
Donald C. Goff, MDPrincipal Investigator

Sites

2 total
Brooklyn, United StatesNew York, United States

Linked catalysts

1
Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia — primary completion2024-03-25

Facts & assertions

4 sourced
Enrollment
15
Phase
PHASE2
Primary Completion Date
2024-03-25
Status
COMPLETED
relationships
The graph out of here
drug
PLIFUS
drug
MRI
drug
lead_sponsor
NYU Langone Health
company
collaborator
The New York Community Trust
company
Doris Duke Charitable Foundation
company
indication
Schizophrenia
indication
Schizophrenia
indication
Schizophrenia Schizoaffective
indication
investigator
Donald C. Goff, MD
person